Cargando…
Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
BACKGROUND: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375664/ https://www.ncbi.nlm.nih.gov/pubmed/31760168 http://dx.doi.org/10.1016/j.breast.2019.10.012 |